You are here : Home / All Sectors / Healthcare / Pharmaceuticals & Drugs / TORRENT PHARMACEUTICALS

TORRENT PHARMACEUTICALS
Intrinsic Value | Fundamental Analysis

Returns | 1W : -2.7% , 1M : 6.3%,1Y : 16%
BOM : 500420     NSE : TORNTPHARM    
LT :  
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : High
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Upward
Pledged Shares : None or < 25%
Jun 18,2021
Price(EOD): Rs. 2,898.35
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
MarketCap: Rs. 49,040.08 Cr
Stock Market Investing Simplified- The best Video Course by Smart-Investing.in

Check out Industry Peers

Peers & Returns1W1M1Y
TORRENT PHARMACEUTICALS -2.7% 6.3% 16%
SUN PHARMACEUTICAL INDUSTRIES -1.3% -2.7% 36.8%
DR REDDYS LABORATORIES -3.2% 0.9% 32.7%
DIVIS LABORATORIES -4.4% 3.7% 87%
CIPLA -1.6% 3.9% 48.5%
BIOCON -3.1% 4.1% 0.7%
AUROBINDO PHARMA -4.2% -7.2% 22%
LUPIN -3% -4% 25.2%
CADILA HEALTHCARE -5.3% 0.9% 70.3%


FUNDAMENTAL ANALYSIS OF TORRENT PHARMACEUTICALS

 
Fundamentals Score
[Last Annual Data : Mar2020 | TTM
Trailing Twelve Months (TTM) is calculated using last 4 quarterly data and is a good substitute to track Annual results.
Learn More
]
Show Me the Stocks with Fundamentals better than TORRENT PHARMACEUTICALS Premium


VALUATION OF TORRENT PHARMACEUTICALS

 
Valuation Score
Ratio Consolidated
P/E
P/B
P/S
47.87
P/E Calculated based on EPS of 60.55
[ Mar2020 - Consolidated Results ]

10.17
P/B Calculated based on Book Value of 284.99
[ Mar2020 - Consolidated Results ]

6.12
P/S Calculated based on Revenues of 8014 Cr
[ TTM - Consolidated Results ]

Show Me the Stocks with Valuation better than TORRENT PHARMACEUTICALS Premium


FAIR VALUE OF TORRENT PHARMACEUTICALS

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
377%
121%
81%

SHARE PRICE MOMENTUM OF TORRENT PHARMACEUTICALS

DEBT

Year Debt/Equity ratio
Standalone Consolidated
2020
2019
2018
Avg_3yrs
1.04
1.12
1.28
1.15
1.21
1.28
1.4
1.3
[Last Annual Data : Mar2020]

PLEDGED SHARES

Pledged Shares
0 %
As on : Mar2021

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad

QTRLY RESULTS

Consolidated Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
-2.91%
-4.12%
7.28%
9.09%
-0.46%
6.2%
30.72%
3.18%
QtrlyTrend
2
Latest Qtr: Mar2021

TORRENT PHARMACEUTICALS related INDICES

BSE Indices1W1M1Y
S&P BSE MOMENTUM -0.9% 5.5% 44.4%
S&P BSE 100 -1% 5% 59.6%
S&P BSE 100 LARGECAP TMC -1% 4.9% 59.4%
S&P BSE CARBONEX -1% 4.9% 60.7%
S&P BSE LARGE MIDCAP -1.2% 4.9% 61.4%
S&P BSE 200 -1.2% 4.9% 62.7%
S&P BSE MIDCAP SELECT INDEX -1.2% 4.9% 69.9%
S&P BSE 250 LARGEMIDCAP -1.3% 5% 63.1%
S&P BSE ALLCAP -1.3% 5.3% 67%
S&P BSE 500 -1.3% 5.1% 65.5%
S&P BSE SENSEX NEXT 50 -1.8% 3.6% 61.2%
S&P BSE MIDSMALLCAP -2% 5.9% 93.9%
S&P BSE MID CAP -2.3% 4.4% 78.6%
S&P BSE HEALTHCARE -2.9% 1.7% 53.8%
NSE Indices1W1M1Y
NIFTY ALPHA LOW-VOLATILTY 30 -0.5% 5% 47.8%
NIFTY 100 -1% 5% 58.3%
NIFTY 200 -1.2% 5% 61.5%
NIFTY 500 -1.2% 5.1% 64.9%
NIFTY500 MULTICAP 50:25:25 -1.4% 5.4% NA
NIFTY LARGE MIDCAP 250 -1.6% 5.2% 71.9%
NIFTY NEXT 50 -2.1% 3.7% 54.8%
NIFTY PHARMA -2.9% 0.4% 41.1%

FAQ [Frequently Asked Questions]


Is TORNTPHARM good for long term investment?

As on 18-Jun-2021, the Fundamentals of TORNTPHARM are Strong and hence it's good for long term investment! See Financial Performance of TORRENT PHARMACEUTICALS . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is TORNTPHARM UnderValued or OverValued?

As on 18-Jun-2021, TORNTPHARM is Over Valued and hence NOT a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of TORNTPHARM ?

As on 18-Jun-2021, the Intrinsic Value of TORNTPHARM is Rs. 1,313.89 determined based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 607.91
Fair Value [Median EV / Sales Model] : Rs. 1,313.89
Fair Value [Median Price / Sales Model] : Rs. 1,605.64
Median Fair Value of TORNTPHARM : Rs. 1,313.89

Is TORNTPHARM trading at a Premium or Discount?

As on 18-Jun-2021, TORNTPHARM is trading at a Premium of 121% based on the Median Intrinsic Value!

Is it right time to buy TORNTPHARM shares?

As on 18-Jun-2021, TORNTPHARM is Over Valued and hence NOT a good buying opportunity according to Share Valuation at this time!

What is the Financial Performance of Industry Peers of TORNTPHARM?

Check out Annual Financials of Industry Peers
Financials of SUN PHARMACEUTICAL INDUSTRIES LTD
Financials of DR REDDYS LABORATORIES LTD
Financials of DIVIS LABORATORIES LTD
Financials of CIPLA LTD
Financials of BIOCON LTD
Financials of AUROBINDO PHARMA LTD
Financials of LUPIN LTD
Financials of CADILA HEALTHCARE LTD
Financials of ABBOTT INDIA LTD
Financials of ALKEM LABORATORIES LTD
Check out Quarterly Results of Industry Peers
Quarterly Results of SUN PHARMACEUTICAL INDUSTRIES LTD
Quarterly Results of DR REDDYS LABORATORIES LTD
Quarterly Results of DIVIS LABORATORIES LTD
Quarterly Results of CIPLA LTD
Quarterly Results of BIOCON LTD
Quarterly Results of AUROBINDO PHARMA LTD
Quarterly Results of LUPIN LTD
Quarterly Results of CADILA HEALTHCARE LTD
Quarterly Results of ABBOTT INDIA LTD
Quarterly Results of ALKEM LABORATORIES LTD

What are the Frequent Comparisons with TORNTPHARM?

Compare Analytics
TORRENT PHARMACEUTICALS LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs DR REDDYS LABORATORIES LTD
TORRENT PHARMACEUTICALS LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD
TORRENT PHARMACEUTICALS LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs BIOCON LTD
TORRENT PHARMACEUTICALS LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs AUROBINDO PHARMA LTD
TORRENT PHARMACEUTICALS LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs LUPIN LTD
TORRENT PHARMACEUTICALS LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs CADILA HEALTHCARE LTD
TORRENT PHARMACEUTICALS LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs ABBOTT INDIA LTD
TORRENT PHARMACEUTICALS LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs ALKEM LABORATORIES LTD
Browse Market Cap of Industry Peers
Market Cap of SUN PHARMACEUTICAL INDUSTRIES LTD
Market Cap of DR REDDYS LABORATORIES LTD
Market Cap of DIVIS LABORATORIES LTD
Market Cap of CIPLA LTD
Market Cap of BIOCON LTD
Market Cap of AUROBINDO PHARMA LTD
Market Cap of LUPIN LTD
Market Cap of CADILA HEALTHCARE LTD
Market Cap of ABBOTT INDIA LTD
Market Cap of ALKEM LABORATORIES LTD

Open Demat Account & Start Investing
    Affiliate Links

Disclosure

SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].


All Stocks : A - Z

ALL   A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z